ACIU Stock Analysis: Buy, Sell, or Hold?
ACIU - AC Immune SA
$2.30
0.05 (2.22%)
▲
5d:
-4.56%
30d:
-4.17%
90d:
-22.82%
HOLD
MODERATE Confidence
Analysis Updated: Jul 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
13d
Get Alerted When ACIU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ACIU shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ACIU shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.77
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.58
35.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACIU is currently trading at $2.30, which is considered oversold relative to its 30-day fair value range of $2.30 to $2.54. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.8) compared to its historical average (15.8). Remarkably, the market is currently pricing in an annual earnings decline of 17.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ACIU is in a strong downtrend. Immediate support is located at $2.12, while resistance sits at $2.62.
Market Sentiment: ACIU has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.49 (+269.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACIU is in a strong downtrend. Immediate support is located at $2.12, while resistance sits at $2.62.
Market Sentiment: ACIU has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.49 (+269.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.30 -
$2.54
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 269.2% below Wall St target ($8.49)
Trading Range Analysis
30-Day Trading Range
$2.30 -
$2.54
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.12
Resistance Level
$2.62
Current Trend
Strong Downtrend
Technical data as of
Jul 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.82
Wall Street Target
$8.49
(+269.2%)
Revenue Growth (YoY)
13.0%
Valuation Discount vs History
-17.6% cheaper
PE vs Historical
8.8 vs 15.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.6%
(market-implied from PE analysis)
1-Year Target
$2.07
(-10%)
2-Year Target
$1.86
(-19%)
3-Year Target
$1.68
(-27%)
3-Yr Target (if PE normalizes)
(PE: 9→16)
$3.00
(+31%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.8 to 15.8
Stabilization Target:
$4.12
(+79.1%)
PE Expansion Potential:
+79.1%
Share & Embed Analysis
Last updated: July 21, 2026 5:15 PM ET
Data refreshes hourly during market hours. Next update: 6:15 PM
Data refreshes hourly during market hours. Next update: 6:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACIU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$415 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$93 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
